These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18504246)

  • 21. Prevalence of anemia in heart failure and its effects on prognosis.
    Belziti CA
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):131-8. PubMed ID: 19210209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Egg on the table.
    Kazama JJ; Kaneko Y
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):14-5. PubMed ID: 19129315
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk stratification in acute decompensated heart failure: the role of cardiac troponin.
    Mueller C
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):680-1. PubMed ID: 18779830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods.
    Maconi M; Cavalca L; Danise P; Cardarelli F; Brini M
    Scand J Clin Lab Invest; 2009; 69(3):365-70. PubMed ID: 19125368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are multiple biomarker testing strategies ready for prime time in heart failure?
    Lee DS; Tu JV
    Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepcidin for clinicians.
    Young B; Zaritsky J
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is anemia in chronic heart failure caused by iron deficiency?
    Westenbrink BD; Voors AA; van Veldhuisen DJ
    J Am Coll Cardiol; 2007 Jun; 49(23):2301-2; author reply 2302. PubMed ID: 17560297
    [No Abstract]   [Full Text] [Related]  

  • 29. A ferritin level >50 microg/L is frequently consistent with iron deficiency.
    Koulaouzidis A; Cottier R; Bhat S; Said E; Linaker BD; Saeed AA
    Eur J Intern Med; 2009 Mar; 20(2):168-70. PubMed ID: 19327606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Learning to use a biomarker. More about B-type natriuretic peptide.
    Mills RM
    J Am Coll Cardiol; 2008 Jun; 51(24):2336-8. PubMed ID: 18549919
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of different diagnostic thresholds and the anaemia-ferritin-transferrin receptor model on the prevalence of anaemia and impaired iron status in older people.
    Tull KI; Hirani V; Ali A; Chua E; Mindell JS
    Age Ageing; 2009 Sep; 38(5):609-13. PubMed ID: 19567482
    [No Abstract]   [Full Text] [Related]  

  • 33. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M; Landais P; Canivet E; Yver L; Bataille P; Brillet G; Commenges B; Koné S
    Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter by Antonelli Incalzi et al regarding article, "endogenous erythropoietin and outcome in heart failure".
    Incalzi RA; Pedone C; Cesari M
    Circulation; 2010 Sep; 122(10):e449; author reply e450. PubMed ID: 20823396
    [No Abstract]   [Full Text] [Related]  

  • 36. Chromogranin A in heart failure.
    Wollert KC; Drexler H
    Eur Heart J; 2002 Jun; 23(12):926-7. PubMed ID: 12069445
    [No Abstract]   [Full Text] [Related]  

  • 37. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anemia in patients with advanced heart failure.
    Ezekowitz JA
    J Am Coll Cardiol; 2007 Jun; 49(23):2301; author reply 2302. PubMed ID: 17560296
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of erythropoietin in a patient with severe congestive heart failure--a case report.
    Carić T; Derek O; Carić D
    Coll Antropol; 2008 Jun; 32(2):641-3. PubMed ID: 18756924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.